Article
HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves' disease in the Japanese.
Human immunology - 1 Jan 2000
Takahashi Megumi, Yasunami Michio, Kubota Sumihisa, Tamai Hajime, Kimura Akinori
Abstract excerpt
Whereas most patients with Graves' disease (GD) have antibodies against the thyrotropin receptor, which are measured as thyrotropin-binding inhibitory immunoglobulin (TBII), the TBII of 10% or less of Japanese patients with GD is undetectable at the first visit and throughout the entire clinical course, and these patients tend to respond well to medications and follow the better clinical course. Therefore, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
